Hyperphosphatemia also increases the concentration of circulating fibroblast growth factor 23, reduces the synthesis of active vitamin D, and produces hypocalcemia, thereby resulting in secondary hyperparathyroidism [50]. This evidence concerns the gene FGF23 and secondary hyperparathyroidism.